EX-99 2 exhibit_1.htm EXHIBIT 1

Exhibit 1
 
Joint Filing Agreement

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of MediWound Ltd. Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. In accordance with Rule 13d-1(k)(1), the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13G and any amendments thereto with respect to the equity securities (as defined in Rule 13d-1(i)) of the issuer, beneficially owned by each of them. This Joint Filing Agreement shall be included as an exhibit to such Schedule 13G and any amendments thereto.
 
This agreement may be executed in any number of counterparts, each of which shall be deemed an original.
 
September 4, 2017
 
   
Dov Yelin
 
  
    /s/ Dov Yelin  
   
By: Dov Yelin
  
   
 
Yair Lapidot
 
  
    /s/ Yair Lapidot  
   
By: Yair Lapidot
 
  
   
Yelin Lapidot Holdings Management Ltd.
 
  
    /s/ Dov Yelin  
   
By: Dov Yelin
  
   
Title: Joint Chief Executive Officer
  
       
   
Yelin Lapidot Mutual Funds Management Ltd.
 
  
    /s/ Or Keren  
   
By: Or Keren
  
   
Title: Joint Chief Executive Officer